Literature DB >> 12695200

Coefficient D(av) is more sensitive than fractional anisotropy in monitoring progression of irreversible tissue damage in focal nonactive multiple sclerosis lesions.

Alessandro Castriota-Scanderbeg1, Fabrizio Fasano, Gisela Hagberg, Ugo Nocentini, Massimo Filippi, Carlo Caltagirone.   

Abstract

BACKGROUND AND
PURPOSE: Persistently hypointense lesions on T1-weighted MR images have been shown to correlate with the amount of axonal damage and clinical disability in multiple sclerosis (MS) patients. The purpose of this study was to investigate whether diffusion coefficient D(av) and fractional anisotropy (FA) are able to detect quantifiable differences among three groups of focal nonactive multiple sclerosis (MS) lesions that appear qualitatively different on T1-weighted images.
METHODS: Conventional and diffusion tensor MR images of the brain were obtained in 18 patients with relapsing remitting (n = 10) or secondary progressive (n=8) MS and in 18 healthy volunteers. Focal nonactive MS lesions were classified as T1 isointense, T1 mildly hypointense, and T1 severely hypointense on unenhanced T1-weighted images. Differences among groups were assessed with one-way analysis of variance using the T1 lesion appearance as the grouping factor and either FA or coefficient D(av) as the dependent measure.
RESULTS: FA was lowest and coefficient D(av) was highest in T1 severely hypointense lesions, and then, in ascending and descending order, respectively, T1 mildly hypointense lesions and T1 isointense lesions. A significant difference in the values of FA was detected only between T1 isointense lesions and T1 severely hypointense lesions (P <.01), whereas no difference was found between T1 mildly hypointense lesions and either one of these two groups. A significant difference was found in the values of coefficient D(av) among all investigated lesion groups. Coefficient D(av) was found to correlate inversely with the T1-weighted contrast ratio (r=-0.58, P <.0001), whereas FA and deltaFA (percentage of FA variation in the lesion, a relative FA measure that minimizes the effect of FA spatial dependence) were not.
CONCLUSION: Coefficient D(av) is more sensitive than FA to variations in the degree of T1 hypointensity and, thus, in the amount of the permanent brain tissue damage in patients with MS.

Entities:  

Mesh:

Year:  2003        PMID: 12695200      PMCID: PMC8148700     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  50 in total

1.  Correction for eddy current induced Bo shifts in diffusion-weighted echo-planar imaging.

Authors:  F Calamante; D A Porter; D G Gadian; A Connelly
Journal:  Magn Reson Med       Date:  1999-01       Impact factor: 4.668

2.  Axonal damage in acute multiple sclerosis lesions.

Authors:  B Ferguson; M K Matyszak; M M Esiri; V H Perry
Journal:  Brain       Date:  1997-03       Impact factor: 13.501

3.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders.

Authors:  D Le Bihan; E Breton; D Lallemand; P Grenier; E Cabanis; M Laval-Jeantet
Journal:  Radiology       Date:  1986-11       Impact factor: 11.105

4.  A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis.

Authors:  I V Allen; S R McKeown
Journal:  J Neurol Sci       Date:  1979-03       Impact factor: 3.181

5.  A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research Group.

Authors:  J H Simon; J Lull; L D Jacobs; R A Rudick; D L Cookfair; R M Herndon; J R Richert; A M Salazar; J Sheeder; D Miller; K McCabe; A Serra; M K Campion; J S Fischer; D E Goodkin; N Simonian; M Lajaunie; K Wende; A Martens-Davidson; R P Kinkel; F E Munschauer
Journal:  Neurology       Date:  2000-07-25       Impact factor: 9.910

6.  Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

Authors:  L Truyen; J H van Waesberghe; M A van Walderveen; B W van Oosten; C H Polman; O R Hommes; H J Adèr; F Barkhof
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

7.  Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements.

Authors:  L A Loevner; R I Grossman; J A Cohen; F J Lexa; D Kessler; D L Kolson
Journal:  Radiology       Date:  1995-08       Impact factor: 11.105

8.  Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy.

Authors:  M A van Walderveen; F Barkhof; P J Pouwels; R A van Schijndel; C H Polman; J A Castelijns
Journal:  Ann Neurol       Date:  1999-07       Impact factor: 10.422

9.  Precise relaxation time measurements of normal-appearing white matter in inflammatory central nervous system disease.

Authors:  D H Miller; G Johnson; P S Tofts; D MacManus; W I McDonald
Journal:  Magn Reson Med       Date:  1989-09       Impact factor: 4.668

10.  Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis.

Authors:  D J Werring; C A Clark; G J Barker; A J Thompson; D H Miller
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

View more
  19 in total

1.  Diffusion tensor imaging applications in multiple sclerosis patients using 3T magnetic resonance: a preliminary study.

Authors:  Lorenzo Testaverde; Laura Caporali; Eugenio Venditti; Giovanni Grillea; Claudio Colonnese
Journal:  Eur Radiol       Date:  2011-12-09       Impact factor: 5.315

Review 2.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

3.  A diffusion longitudinal MR imaging study in normal-appearing white matter in untreated relapsing-remitting multiple sclerosis.

Authors:  F G Garaci; V Colangelo; A Ludovici; F Gaudiello; S Marziali; D Centonze; L Boffa; G Simonetti; R Floris
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

4.  Magnetic resonance monitoring of lesion evolution in multiple sclerosis.

Authors:  Alex Rovira; Cristina Auger; Juli Alonso
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

5.  Multi-modal quantitative MRI investigation of brain tissue neurodegeneration in multiple sclerosis.

Authors:  Khader M Hasan; Indika S Walimuni; Humaira Abid; Jerry S Wolinsky; Ponnada A Narayana
Journal:  J Magn Reson Imaging       Date:  2012-01-12       Impact factor: 4.813

Review 6.  Multiple sclerosis: the role of MR imaging.

Authors:  Y Ge
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

7.  Diffusion tensor magnetic resonance imaging in patients with multiple sclerosis and its relationship with disability.

Authors:  S Temel; H D Keklikoğlu; H D Kekliğkoğlu; G Vural; O Deniz; K Ercan
Journal:  Neuroradiol J       Date:  2013-03-08

8.  Diffusion tensor imaging of frontal white matter and executive functioning in cocaine-exposed children.

Authors:  Tamara Duckworth Warner; Marylou Behnke; Fonda Davis Eyler; Kyle Padgett; Christiana Leonard; Wei Hou; Cynthia Wilson Garvan; Ilona M Schmalfuss; Stephen J Blackband
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

9.  Relevance of the skewness index in DTI exploration of multiple sclerosis.

Authors:  Eliane Graulières; Jean-Albert Lotterie; Emmanuelle Cassol; Angélique Gerdelat; Michel Clanet; Isabelle Berry
Journal:  MAGMA       Date:  2008-11-08       Impact factor: 2.310

10.  Genetic markers of cholesterol transport and gray matter diffusion: a preliminary study of the CETP I405V polymorphism.

Authors:  Lauren E Salminen; Peter R Schofield; Kerrie D Pierce; Xi Luo; Yi Zhao; David H Laidlaw; Ryan P Cabeen; Thomas E Conturo; Elizabeth M Lane; Jodi M Heaps; Jacob D Bolzenius; Laurie M Baker; Sarah A Cooley; Staci Scott; Lee M Cagle; Robert H Paul
Journal:  J Neural Transm (Vienna)       Date:  2015-08-08       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.